Bonnie L. Bassler - 03 Feb 2023 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**Bonnie L. Bassler
Issuer symbol
REGN
Transactions as of
03 Feb 2023
Net transactions value
-$406,409
Form type
4
Filing time
07 Feb 2023, 15:09:53 UTC
Previous filing
05 Jan 2023
Next filing
27 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $388,950 +1,021 +82% $380.95 2,268 03 Feb 2023 Direct F1
transaction REGN Common Stock Sale $795,359 -1,021 -45% $779.00 1,247 03 Feb 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -1,021 -22% $0.000000 3,720 03 Feb 2023 Common Stock 1,021 $380.95 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.